BCIQ Profiles

Company Profile Report

TCR2 seeks IPO as first program slated to enter clinic

Looking to bring at least one of its cell therapy programs to the clinic in 2019, TCR2 Therapeutics Inc. (Cambridge, Mass.) filed on Dec. 28 to raise $100 million

Read the full 298 word article

How to gain access

Continue reading with a
two-week free trial.